BioPharmSignal logoBioPharmSignal

Biotech News

New Men’s Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action

Progyny (PGNY)ProgynyCompany update

75% of men see fertility as an equal gender topic and acknowledge the connection between fertility health and their overall health, yet only 46% of men with a fertility issue have sought support due to stigma, cost, and other barriers. NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc .

Open original release

Related news

PGNYProgyny2026-04-16 13:06 EST

Progyny Expands Access to Fertility and Women’s Health with Industry’s First Fully Insured Supplemental Plan

PGNYProgyny2026-05-28 13:04 EST

New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System

View all latest news

Progyny

Progyny is a fertility and family-building benefits company serving employers and their members through specialized reproductive-health services.

Recent company news

PGNYProgyny2026-05-28 13:04 EST

New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System

PGNYProgyny2026-05-26 12:00 EST

Progyny, Inc. Announces Share Repurchase Program

PGNYProgyny2026-05-11 14:57 EST

Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference

PGNYProgyny2026-05-07 20:01 EST

Progyny, Inc. Announces First Quarter 2026 Results

PGNYProgyny2026-04-23 17:56 EST

Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report

Stock data

Close
31.59 USD
Market cap
1.97B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States